Metacognitive Therapy for Comorbid Insomnia

Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00235365

Enrollment

Registered

2005-10-10

Start date

2009-08-31

Completion date

2011-01-31

Last updated

2012-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary Insomnia

Brief summary

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Detailed description

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Interventions

BEHAVIORALmeta-cognitive therapy

Meta-cognitive therapy

OTHERwaiting list

waiting list control

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Insomnia secondary to a primary psychiatric disorder

Exclusion criteria

* substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.

Design outcomes

Primary

Measure	Time frame
Scores on rating scales for sleep quality	one year

Secondary

Measure	Time frame
Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing.	one year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026